This is the ground floor—but the foundation couldn’t be more solid. In addition to our peer-reviewed scientific validation of industry-leading accuracy, we also have:

  • A $1.8 million NIH grant awarded from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a division of the National Institutes of Health (NIH)
  • An active research collaboration with NIH/NIDDK
  • A broad arrange of domestic and international channel partnership opportunities
  • Proprietary technology and issued patents protecting key features of Lume™
  • Selection in StartUp Health—a revolutionary new model for transforming health by organizing, supporting and investing in a digital health portfolio of 200 Health Transformer companies spanning six continents, 19 countries and 60+ cities

We will initially sell Lume for a one-time fee of $200 to the 53,000 medical and employer-based commercial weight loss providers, and expand by using them as channel partners to reach another 91 million consumers attempting weight loss on their own. Three additional products will generate recurring revenue.

Our solution, Lume, is developed, tested, patented, and validated.